Zieve syndrome
Zieve syndrome is also known as alcoholic hyperlipidemia syndrome, icteric transient hyperlipidemia-hemolytic anemia syndrome, and alcoholism hyperlipidemia-hemolytic syndrome. It was first reported by Zieve in 1958 and named Zieve syndrome by Balcerzak in 1968. It refers to a group of diseases in which chronic alcoholism patients have jaundice, hyperlipidemia, and hemolytic anemia.
-
Site of disease:
Blood vessels skin whole body -
Infectious :
Not contagious -
Frequent population:
All groups -
Related symptoms:
Liver enlargement poor appetite ascites cirrhosis dyslipidemia -
Concurrent disease:
Related Drugs
Gemfibrozil Capsules
Indication: Suitable for primary hyperlipidemia.
Manufacturer:
Shenzhen Neptunus Pharmaceutical Co., Ltd.
Gemfibrozil Capsules
Indication: Suitable for primary hyperlipidemia.
Manufacturer:
Yabao Pharmaceutical Group Co., Ltd.
Gemfibrozil Capsules
Indication: Suitable for primary hyperlipidemia.
Manufacturer:
Changzhou Pharmaceutical Factory Co., Ltd.
Fenofibrate Tablets
Indication: This product is used to treat hyperlipidemia in adults who have not responded well to dietary control therapy. Its effect on lowering triglycerides and mixed hyperlipidemia is more obvious than its effect on cholesterol.
Related Ingredients